tiprankstipranks
Cormedix (DE:19KA)
STUTTGART:19KA

Cormedix (19KA) Cash flow

1 Followers

Cormedix Cash Flow

DE:19KA's free cash flow for Q4 2023 was $-11.04M. For the 2023 fiscal year, DE:19KA's free cash flow was decreased by $-14.16M and operating cash flow was $-10.75M. See a summary of the company’s cash flow.
Cash Flow
TTM
Dec 23Dec 22Dec 21Dec 20Dec 19
Operating Cash Flow
$ -38.41M$ -38.41M$ -24.36M$ -21.16M$ -21.97M$ -15.05M
Investing Cash Flow
$ -17.06M$ -17.06M$ -3.71M$ -9.13M$ 7.43M$ -12.02M
Financing Cash Flow
$ 55.92M$ 55.92M$ 17.90M$ 41.76M$ 40.10M$ 25.80M
Cash Flow From Discontinued Operation
------
Other Cash Adjustment Inside Changein Cash
------
End Cash Position
$ 142.46M$ 43.82M$ 43.37M$ 53.55M$ 42.10M$ 16.53M
Income Tax Paid Supplemental Data
------
Interest Paid Supplemental Data
$ 34.30K$ 34.30K$ 26.52K$ 15.94K$ 33.23K$ 12.55K
Issuance Of Capital Stock
$ 55.83M$ 55.83M$ 17.77M$ 41.46M$ 39.69M$ 15.23M
Issuance Of Debt
-----$ 0.00
Repayment Of Debt
------
Free Cash Flow
$ -38.74M$ -38.74M$ -24.58M$ -22.58M$ -22.08M$ -15.09M
Domestic Sales
------
Foreign Sales
------
Currency in USD

Cormedix Cash Flow

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis